The Inovirus Pf4 Triggers Antiviral Responses and Disrupts the Proliferation of Airway Basal Epithelial Cells

BACKGROUND: The inovirus Pf4 is a lysogenic bacteriophage of Pseudomonas aeruginosa (Pa). People with Cystic Fibrosis (pwCF) experience chronic airway infection with Pa and a significant proportion have high numbers of Pf4 in their airway secretions. Given the known severe damage in the airways of Pa-infected pwCF, we hypothesized a high Pf4 burden can affect airway healing and inflammatory responses. In the airway, basal epithelial cells (BCs) are a multipotent stem cell population critical to epithelium homeostasis and repair. We sought to investigate the transcriptional responses of BCs under conditions that emulate infection with Pa and exposure to high Pf4 burden.

METHODS: Primary BCs isolated from pwCF and wild-type (WT) donors were cultured in vitro and exposed to Pf4 or bacterial Lipopolysaccharide (LPS) followed by transcriptomic and functional assays.

RESULTS: We found that BCs internalized Pf4 and this elicits a strong antiviral response as well as neutrophil chemokine production. Further, we found that BCs that take up Pf4 demonstrate defective migration and proliferation.

CONCLUSIONS: Our findings are highly suggestive of Pf4 playing a role in the pathogenicity of Pa in the airways. These findings provide additional evidence for the ability of inoviruses to interact with mammalian cells and disrupt cell function.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:16

Enthalten in:

Viruses - 16(2024), 1 vom: 22. Jan.

Sprache:

Englisch

Beteiligte Personen:

Popescu, Medeea C [VerfasserIn]
Haddock, Naomi L [VerfasserIn]
Burgener, Elizabeth B [VerfasserIn]
Rojas-Hernandez, Laura S [VerfasserIn]
Kaber, Gernot [VerfasserIn]
Hargil, Aviv [VerfasserIn]
Bollyky, Paul L [VerfasserIn]
Milla, Carlos E [VerfasserIn]

Links:

Volltext

Themen:

Antiviral Agents
Basal epithelial cells
Cystic fibrosis
Inovirus
Journal Article
Pf4
Pseudomonas

Anmerkungen:

Date Completed 29.01.2024

Date Revised 27.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.3390/v16010165

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367663856